Selected article for: "case series and control group"
Author: Fallahi, Poupak; Ferrari, Silvia Martina; Politti, Ugo; Giuggioli, Dilia; Ferri, Clodoveo; Antonelli, Alessandro
Title: Autoimmune and Neoplastic Thyroid Diseases Associated with Hepatitis C Chronic Infection
  • Document date: 2014_10_13
    • ID: 0go1vl9q_33
    Snippet: The prevalence of thyroid cancer was also investigated in a series of unselected 94 MC + HCV patients in comparison with a gender-and age-matched control group obtained from a sample of the general population (470 subjects). The prevalence of thyroid nodules was higher in control subjects than in MC + HCV patients (65.3% versus 54.8%), even though not significantly. Two patients with PTC were found in the MC + HCV series, while no case was observ.....
    Document: The prevalence of thyroid cancer was also investigated in a series of unselected 94 MC + HCV patients in comparison with a gender-and age-matched control group obtained from a sample of the general population (470 subjects). The prevalence of thyroid nodules was higher in control subjects than in MC + HCV patients (65.3% versus 54.8%), even though not significantly. Two patients with PTC were found in the MC + HCV series, while no case was observed among controls ( = 0.001). Lymphocytic infiltration was observed in the thyroid tissue in both MC + HCV patients with PTC [84] . Other studies have confirmed an association between AT and thyroid cancer [85, 86] . Accordingly, features of AT were observed more frequently in HCV patients than in controls suggesting that AT may be a predisposing condition for thyroid cancer [87] . Since about 15-30% of HCV patients may show an aggressive disease, for example, lung metastases, difficult to treat [88, 89] , the finding of an 4 International Journal of Endocrinology increased prevalence of thyroid cancer in these patients is clinically relevant [90] .

    Search related documents:
    Co phrase search for related documents
    • age match and general population: 1, 2
    • age match gender and general population: 1, 2
    • aggressive disease and control group: 1, 2
    • aggressive disease and general population: 1, 2
    • aggressive disease and lung metastasis: 1
    • aggressive disease and thyroid cancer: 1
    • control group and general population: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
    • control group and HCV patient: 1, 2
    • control group and lung metastasis: 1
    • control group and lymphocytic infiltration: 1, 2
    • control group and thyroid cancer: 1
    • general population and HCV patient: 1
    • general population and lung metastasis: 1
    • general population and thyroid cancer: 1, 2, 3, 4, 5